For research use only. Not for therapeutic Use.
Relenopride hydrochloride is a selective serotonin 5-HT4 receptor agonist, investigated for its potential in treating gastrointestinal disorders such as irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD). By stimulating 5-HT4 receptors, Relenopride enhances gastrointestinal motility and accelerates gastric emptying, alleviating symptoms like bloating, discomfort, and delayed digestion. Its targeted mechanism of action offers a promising therapeutic option for managing chronic gastrointestinal conditions, with ongoing research focused on its safety, efficacy, and tolerability in clinical settings.
| Catalog Number | I008998 |
| CAS Number | 1221416-42-7 |
| Synonyms | [(1S)-3-[4-[[(4-amino-5-chloro-2-methoxybenzoyl)amino]methyl]piperidin-1-yl]-1-(4-fluorophenyl)propyl] carbamate;hydrochloride |
| Molecular Formula | C24H31Cl2FN4O4 |
| Purity | ≥95% |
| InChI | InChI=1S/C24H30ClFN4O4.ClH/c1-33-22-13-20(27)19(25)12-18(22)23(31)29-14-15-6-9-30(10-7-15)11-8-21(34-24(28)32)16-2-4-17(26)5-3-16;/h2-5,12-13,15,21H,6-11,14,27H2,1H3,(H2,28,32)(H,29,31);1H/t21-;/m0./s1 |
| InChIKey | DMJJYQFHCCNBNI-BOXHHOBZSA-N |
| SMILES | COC1=CC(=C(C=C1C(=O)NCC2CCN(CC2)CCC(C3=CC=C(C=C3)F)OC(=O)N)Cl)N.Cl |
